Showing 1 - 20 results of 20 for search 'N S Besova', query time: 0.03s
Refine Results
-
1
-
2
Choice of adjuvant drug therapy on the basis of the molecular classification of breast cancer by N. S. Besova
Published 2014-07-01
Article -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Case report of the rapid achievement of sustained and long-term remission resulting from the use of ramucirumab plus paclitaxel in the second-line treatment of a patient with disse... by T. A. Titova, N. S. Besova, V. A. Gorbunova, Yu. P. Kuvshinov, A. A. Filatov, A. F. Ketsba, A. A. Fedenko
Published 2018-07-01
Article -
13
Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting by N. S. Besova, Т. А. Titova, А. А. Tryakin, Е. V. Artamonova, Е. S. Obarevich, D. L. Stroyakovskiy, О. Е. Kalinin, I. S. Stilidi
Published 2021-06-01
Article -
14
Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer by N. S. Besova, T. A. Titova, D. L. Stroyakovsky, E. V. Perminova, S. G. Bagrova, E. S. Obarevich, V. A. Gorbunova, E. V. Artamonova, I. S. Stilidi
Published 2019-06-01
Article -
15
REAL-LIFE CLINICAL UTILITY OF RAMUCIRUMAB FOR THE TREATMENT OF PATIENTS WITH DISSEMINATED GASTRIC ADENOCARCINOMA: PRELIMINARY REVIEW OF THE EXPERIENCE OF BLOKHIN RUSSIAN CANCE... by N. S. Besova, T. A. Titova, V. A. Gorbunova, O. O. Gordeeva, A. A. Tryakin, A. V. Snegovoy, R. Yu. Nasyrova, A. A. Rumyantsev, E. A. Voroshilova, E. V. Artamonova
Published 2017-11-01
Article -
16
THE USE OF PACLITAXEL IN CHEMORADIOTHERAPY OF PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL: A PILOT STUDY by S. S. Gordeev, V. A. Gorbunova, S. I. Tkachev, V. V. Glebovskaya, N. S. Besova, Yu. E. Suraeva, M. Yu. Fedyanin, V. A. Ivanov, V. S. Anan’ev, A. G. Malikhov, A. O. Rasulov
Published 2017-01-01
Article -
17
Hyperthermia is an additional option in the treatment of squamous cell cancer of the anal canal by V V Glebovskaya, S I Tkachev, S M Ivanov, A V Nazarenko, A O Rasulov, S S Gordeev, P V Bulychkin, N S Besova, U A Barsukov, O P Trofimova, T N Borisova, E V Timoshkina
Published 2017-06-01
Article -
18
Results of the use of ramucirumab in combination with paclitaxel or ramucirumab monotherapy as the second line treatment in patients with disseminated HER2-negative gastric or card... by N. S. Besova, T. A. Titova, E. V. Trusilova, V. A. Gorbunova, A. A. Tryakin, O. O. Gordeeva, A. A. Rumyantsev, R. Yu. Nasyrova, L. G. Zhukova, A. V. Snegovoy, E. V. Artamonova, L. V. Manzyuk, A. A. Fedenko
Published 2018-07-01
Article -
19
Tolerance of ramucirumab in the second-line therapy of patients with disseminated gastric cancer in the routine clinical practice of Russia by N. S. Besova, T. A. Titova, E. V. Artamonova, D. L. Stroyakovskiy, E. V. Perminova, D. Yu. Yukal’chuk, D. M. Ponomarenko, N. P. Belyak, R. V. Orlova, G. M. Teletaeva, E. Yu. Ratner, A. S. Mochalova, O. O. Gordeeva, A. S. Zhabina, S. V. Gamayunov, A. V. Smolin, A. Yu. Povyshev, M. I. Andrievskikh, A. A. Tryakin, I. S. Stilidi
Published 2019-12-01
Article -
20
Analysis of prognostic factors for survival in the Russian population of patients with disseminated gastric cancer, who received ramucirumab as secondline therapy in the RAMSELGA t... by N. S. Besova, T. A. Titova, Е. V. Artamonova, A. A. Tryakin, D. L. Stroyakovskiy, E. V. Perminova, D. Yu. Yukalchuk, D. M. Ponomarenko, N. P. Belyak, R. V. Orlova, G. M. Teletaeva, E. Yu. Ratner, A. S. Mochalova, O. O. Gordeeva, A. S. Zhabina, S. V. Gamayunov, A. V. Smolin, A. Yu. Povyshev, M. I. Andrievskikh, I. S. Stilidi
Published 2020-07-01
Article